Keros Therapeutics (KROS) Share-based Compensation (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 83.27% |
| Sep 30, 2025 | -53.34% |
| Jun 30, 2025 | -3.62% |
| Mar 31, 2025 | -3.66% |
| Dec 31, 2024 | 4.34% |
| Sep 30, 2024 | 0.36% |
| Jun 30, 2024 | 8.86% |
| Mar 31, 2024 | 10.19% |
| Dec 31, 2023 | -15.92% |
| Sep 30, 2023 | 23.72% |
| Jun 30, 2023 | 23.81% |
| Mar 31, 2023 | 19.83% |
| Dec 31, 2022 | -0.17% |
| Sep 30, 2022 | -0.83% |
| Jun 30, 2022 | 9.25% |
| Mar 31, 2022 | 33.17% |
| Dec 31, 2021 | 6.84% |
| Sep 30, 2021 | 8.25% |
| Jun 30, 2021 | 14.23% |
| Mar 31, 2021 | 63.86% |
| Dec 31, 2020 | 6.88% |
| Sep 30, 2020 | 25.02% |
| Jun 30, 2020 | 9,391.67% |
| Mar 31, 2020 | -33.33% |
| Dec 31, 2019 | 5.88% |
| Sep 30, 2019 | 30.77% |
| Jun 30, 2019 | 18.18% |